Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Stemtech's free cash flow for the twelve months ending Sep 30, 2026 was -$650.12K. For fiscal 2025 it was -$483.58K.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$483.58K | – |
| FY2024 | Dec 31, 2024 | -$601.20K | – |
| FY2023 | Dec 31, 2023 | -$2.04M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$296.39K | -1286.9% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$54.84K | -173.2% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$425.88K | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $127.00K | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $24.97K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $74.95K | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$710.51K | -169.8% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$270.92K | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$1.17M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$176.36K | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $1.02M | – |
See a number that looks wrong?